Search results

Filters
Close
ADDED DATE
Added date
TOPICS Please select
WATCH / LISTEN / READ TIME
SK Channels as a New AAD Target
Author(s): Arnela Saljic , Jordi Heijman , Dobromir Dobrev Added: 1 year ago

Electrophysiology & Arrhythmia
Aldosteronism Linked to AF and Stroke Risk in Older Adults
Added: 2 months ago Source:  Radcliffe CVRM
A spectrum of primary aldosteronism, indicated by a higher aldosterone-renin ratio (ARR), may contribute to an increased risk of atrial fibrillation (AF) and ischaemic stroke in older adults, according to a new cohort study analysis.¹MethodologyThis prospective cohort analysis used data from the Atherosclerosis Risk in Communities (ARIC) study. The investigation included 3,477 community-dwelling… View more

MI/ACS

Prevention & Chronic Conditions
Higher ARR Linked to AF and Stroke Risk in Older Adults
Added: 3 months ago Source:  Radcliffe CVRM
Renin-independent aldosteronism is a common and often underrecognised condition. A new analysis from the Atherosclerosis Risk in Communities (ARIC) study has investigated whether this broader spectrum of aldosteronism is associated with incident cardiovascular disease (CVD) in older, community-dwelling adults.¹MethodologyThis prospective cohort analysis included 3,477 participants from the ARIC… View more

Prevention & Chronic Conditions

Cardiovascular Kidney Metabolic
Empagliflozin and Finerenone: Hyperkalemia Risk in CKD
Added: 3 months ago Source:  Radcliffe CVRM
The CONFIDENCE trial investigated the efficacy of dual Empagliflozin & Finerenone therapy in compound CKD-T2D patients compared to Finerenone monotherapy in hyperkalemia prevention. The results suggested that dual therapy did not significantly mitigate hyperkalemia risk compared to solitary Finerenone administration.¹MethodologyThe CONFIDENCE trial was a double-blind, randomised, controlled study… View more

Cardiovascular Kidney Metabolic
AHA 24 Late-Breaking Discussion: REALIZE-K
Author(s): Harriette Van Spall , Mikhail Kosiborod Added: 1 year ago
AHA Conference 2024 — REALIZE-K: Impact of sodium zirconium cyclosilicate (SZC) on HFrEF patient's potassium levels whilst on spironolactone.Late-Breaker Host, Dr Harriette Van Spall (McMaster University, CA) is joined onsite by Dr Mikhail Kosiborod (Saint Luke's Mid America Heart Institute, US) to discuss the findings from the REALIZE-K Study (NCT04676646; AstraZeneca).REALIZE-K is a phase 4… View more

Prevention & Chronic Conditions

Cardiovascular Kidney Metabolic
Jozine ter Maaten
Research Area(s) / Expertise:

Heart Failure

 Job title: Cardiologist
Dr Jozine ter Maaten is a cardiologist at the University Medical Center Groningen, specializing in acute heart failure. Her research focuses on understanding congestion and improving diuretic response and outcomes in patients with this condition. Dr ter Maaten completed her PhD on 'Diuretic response and renal biomarkers in heart failure' in 2016 and has since been actively involved in research… View more
30th Annual Meeting of the ISCP
Author(s): Diego Manuel de la Eranueva , Ignacio Quevedo , Adela Castro Garcia , et al Added: 2 months ago

Prevention & Chronic Conditions

Heart Failure
Research Area(s) / Expertise: Job title: Nephrologist
Dr Areef Ishani is a Nephrologist and Director of the Primary and Specialty Care Service Line atMinneapolis VA Health Care System, Minneapolis, MN, US. His areas of expertise are chronic kidney disease, end-stage renal disease, high potassium level, small lymphocytic lymphoma, and kidney transplant. View more
30th Annual Meeting of the ISCP
Author(s): Paula Bouzón Iglesias , Alejandro Gullón de la Roza , Laura Pérez Bacigalupe , et al Added: 2 months ago

Intervention

Prevention & Chronic Conditions